Administration of corticosteroid therapy for HELLP syndrome in pregnant women: evidences from seven randomized controlled trials

References

• Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142(2):159–10. doi: 10.1016/S0002-9378(16)32330-4
   PubMed Web of Science ®Google Scholar
• Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. Bmc Pregnancy Childbirth. 2009;9(1):8. doi: 10.1186/1471-2393-9-8
   PubMedGoogle Scholar
• Lam MTC, Dierking E. Intensive care unit issues in eclampsia and HELLP syndrome. Int J Crit Illn Inj Sci. 2017;7(3):136–141. doi: 10.4103/IJCIIS.IJCIIS_33_17
   PubMedGoogle Scholar
• Sadaf N, Haq G, Shukar-Ud-Din S. Maternal and foetal outcome in HELLP syndrome at tertiary care hospital. J Pak Med Assoc. 2013;63(12):1500–1503.
   PubMed Web of Science ®Google Scholar
• Abramovici D, Friedman SA, Mercer BM, et al. Neonatal outcome in severe preeclampsia at 24 to 36 weeks’ gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol. 1999;180(1):221–225. doi: 10.1016/S0002-9378(99)70178-X
   PubMed Web of Science ®Google Scholar
• Abildgaard U, Heimdal K. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol. 2013;166(2):117–123. doi: 10.1016/j.ejogrb.2012.09.026
   PubMed Web of Science ®Google Scholar
• Geary M. The HELLP syndrome. Br J Obstet Gynaecol. 1997;104(8):887–891. doi: 10.1111/j.1471-0528.1997.tb14346.x
   PubMedGoogle Scholar
• Amylidi-Mohr S, Kubias J, Neumann S, et al. Reducing the risk of preterm preeclampsia: comparison of two first trimester screening and treatment strategies in a single centre in Switzerland. Geburtshilfe Frauenheilkd. 2021;81(12):1354–1361. doi: 10.1055/a-1332-1437
   PubMed Web of Science ®Google Scholar
• Wallace K, Harris S, Addison A, et al. HELLP syndrome: pathophysiology and Current therapies. Curr Pharm Biotechnol. 2018;19(10):816–826. doi: 10.2174/1389201019666180712115215
   PubMed Web of Science ®Google Scholar
• Wallace K, Martin JN Jr., Tam Tam K, et al. Seeking the mechanism(s) of action for corticosteroids in HELLP syndrome: SMASH study. Am J Obstet Gynecol. 2013;208(5):380.e381–388. doi: 10.1016/j.ajog.2013.01.049
   Web of Science ®Google Scholar
• Jiménez KM, Morel A, Parada-Niño L, et al. Identifying new potential genetic biomarkers for HELLP syndrome using massive parallel sequencing. Pregnancy Hypertens. 2020;22:181–190. doi: 10.1016/j.preghy.2020.09.003
   PubMed Web of Science ®Google Scholar
• Cam T, Cimilli Senocak GN, Ozturk N, et al. May human epididymis 4 protein play a role in the etiopathogenesis of hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome? J Obstetrics Gynaecol Res. 2021;47(7):2324–2328. doi: 10.1111/jog.14808
   PubMed Web of Science ®Google Scholar
• Gardikioti A, Venou T-M, Gavriilaki E, et al. Molecular Advances in Preeclampsia and HELLP Syndrome. Int J Mol Sci. 2022;23(7):3851. doi: 10.3390/ijms23073851
   PubMed Web of Science ®Google Scholar
• Ozer A, Kanat-Pektas M, Ozer S, et al. The effects of betamethasone treatment on clinical and laboratory features of pregnant women with HELLP syndrome. Arch Gynecol Obstetrics. 2009;280(1):65–70. doi: 10.1007/s00404-008-0865-3
   PubMed Web of Science ®Google Scholar
• Watterberg K, Aucott S, Benitz W, et al. The Apgar score. Pediatrics. 2015;136(4):819–822. doi: 10.1542/peds.2015-2651
   PubMed Web of Science ®Google Scholar
• Woudstra DM, Chandra S, Hofmeyr GJ, et al. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev. 2010;2010Cd008148. doi: 10.1002/14651858.CD008148.pub2
   Web of Science ®Google Scholar
• Yang L, Ren C, Mao M, et al. Prognostic factors of the efficacy of High-dose corticosteroid therapy in hemolysis, elevated liver enzymes, and Low platelet count syndrome during pregnancy: a meta-analysis. Medicine. 2016;95(13):e3203. doi: 10.1097/MD.0000000000003203
   PubMed Web of Science ®Google Scholar
• Simó R, Hernández C. New insights into treating early and advanced stage diabetic retinopathy. Int J Mol Sci. 2022;23(15):8513. doi: 10.3390/ijms23158513
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898
   PubMed Web of Science ®Google Scholar
• Andrade C. Mean difference, standardized mean difference (SMD), and their use in meta-analysis. J Clin Psychiatry. 2020;81:20f13681. doi: 10.4088/JCP.20f13681
   PubMed Web of Science ®Google Scholar
• Barrilleaux PS, Martin JN Jr., Klauser CK, et al. Postpartum intravenous dexamethasone for severely preeclamptic patients without hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome: a randomized trial. Obstet & Gynecol. 2005;105(4):843–848. doi: 10.1097/01.AOG.0000154887.57440.d1
   PubMed Web of Science ®Google Scholar
• Fonseca JE, Méndez F, Cataño C, et al. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2005;193(5):1591–1598. doi: 10.1016/j.ajog.2005.07.037
   PubMed Web of Science ®Google Scholar
• Fonseca JE, Otero JC, Messa C. Dexamethasone for the treatment of class I HELLP syndrome: a double-blind, placebo-controlled, multicenter, randomized clinical trial. Pregnancy Hypertens. 2019;17:158–164. doi: 10.1016/j.preghy.2019.06.003
   PubMed Web of Science ®Google Scholar
• Katz L, de Amorim MM, Figueiroa JN, et al. Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2008;198(3):283.e281–288. doi: 10.1016/j.ajog.2007.10.797
   Web of Science ®Google Scholar
• Magann EF, Bass D, Chauhan SP, et al. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol. 1994;171(4):1148–1153. doi: 10.1016/0002-9378(94)90054-X
   PubMed Web of Science ®Google Scholar
• van Runnard Heimel PJ, Huisjes AJ, Franx A, et al. A randomised placebo-controlled trial of prolonged prednisolone administration to patients with HELLP syndrome remote from term. Eur J Obstet Gynecol Reprod Biol. 2006;128(1–2):187–193. doi: 10.1016/j.ejogrb.2005.11.041
   PubMed Web of Science ®Google Scholar
• Mao M, Chen C. Corticosteroid therapy for management of hemolysis, elevated liver enzymes, and Low platelet count (HELLP) syndrome: a meta-analysis. Med Sci Monit. 2015;21:3777–3783. doi: 10.12659/MSM.895220
   PubMed Web of Science ®Google Scholar
• Clenney TL, Viera AJ. Corticosteroids for HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome. BMJ. 2004;329(7460):270–272. doi: 10.1136/bmj.329.7460.270
   PubMedGoogle Scholar
• Morhart P, Gärtner J, Weiss C, et al. Influence of timing of antenatal corticosteroid administration on morbidity of preterm neonates. Vivo (Athens, Greece). 2022;36(4):1777–1784. doi: 10.21873/invivo.12891
   PubMed Web of Science ®Google Scholar